licaminlimab

Drug identity checked against registry records

Also recorded as OCS-02

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye DiseaseNCT05896670OculisPhase 2Completed2024-03-27Actual
A Clinical Study Evaluating Licaminlimab for Dry Eye DiseaseNCT07548632OculisPhase 2, Phase 3Active not recruiting2026-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.